The potency and nature of the inhibitory effect of various cationic drugs on the transport of choline across the placental syncytial microvillus membrane was investigated. Tetraethylammonium, a model substrate for organic cation transport, was a poor inhibitor. Enlarging the degree of alkylation of the quaternary ammonium increased the inhibitory effect, in proportion with increasing lipophilicity. Log concentration vs % control uptake curves showed marked differences in inhibitory potency for the different cationic drugs. Hemicholinium-3 inhibited mediated choline uptake in the micromolar range, whereas atropine and mepiperphenidol were less potent. The H2-receptor antagonists cimetidine, ranitidine, and famotidine inhibited choline uptake in the millimolar ranges. Dixon analysis revealed a competitive nature of inhibition for hemicholinium-3 and atropine (.K, = 40 pM and 1.2 mM, respectively). Cimetidine interacted noncompetitively {Kt = 3,4 mM). Since relatively high concentrations were needed to reach half maximal inhibition, impairment of fetal choline supply due to maternal drug use during pregnancy is not to be expected.
Choline, a cationic quaternary ammonium compound, is an essential substrate for adequate growth and develop ment of the fetus. Choline serves as a substrate for the synthesis of phospholipids and acetylcholine. Since the human placenta and fetus do not synthesize choline, fetal supply is highly dependent on the proper transfer of this nutrient from maternal to fetal circulation [1]. The initial step in placental transfer involves uptake across the syn cytial microvillus membrane of the trophoblast. In the perfused human placental cotyledon, trans-placental transfer was slow in contrast to the fast and high pla cental uptake [2]. Since there was a small excess transplacental choline transfer in comparison with the extra cellular marker mannitol, preferentially towards the fetal circulation, the human placenta possesses a unidirec tional pathway for choline in the maternal to fetal direc tion. Placental choline uptake at the maternal side was inhibited by choline itself and at the fetal side by HC-34 a well-known competitive inhibitor of choline transport, suggesting the existence of specific transport systems at both sides of the trophoblast. Evidence for mediated tro- t Abbreviations: HC-3, hemicholinium-3; Hepes, 2-aminohydroxyethylpiperazine-N-2-ethanesulfonic acid; Mes, 2(Nmorpholino)ethanesulfonic acid; NMN, n-methylnicotinamide; pH(, pH inside the vesicle; pH0, pH outside the vesicle; SMMV, syncytial microvillus membrane vesicles; TMA, tetramethylammonium-bromide; TEA, tetraethylamrnoniurn-bromide; TPrA, tetrapropylammonium-bromide; TBA, tetrabutylammonium-hydrogensulfate; TPeA, tetrapentylammonium-bromide; THA, tetrahexylammonium-bromide; val, valinomycin. phoblastic choline uptake was also found in human pla cental fragments, which accumulated choline against a concentration gradient, inhibitable by HC-3 with a K,of 0.45 mM. However, because uptake in fragments is the net result of transport across both the syncytial microvil lus and basal membranes, it is impossible to differentiate between inhibition of the choline transporter at both sides of the trophoblast. Isolated vesicles of these mem branes are a more appropriate tool for investigating the location and nature of such interactions. Recently, we described the mechanisms of choline uptake into isolated SMMV of human term placenta [3]. Uptake was not sodium-dependent or coupled to proton transport. An inside negative membrane potential enhanced choline uptake, showing that a negatively charged inner mem brane surface acts as a driving force for trophoblastic choline uptake. Mediated transport was confirmed by the ira/w-stimulatory effect of unlabeled choline and cis~ inhibitory effects of HC-3, the organic cation transport inhibitor mepiperphenidol, and H2~receptor antagonists. and NMN, did not inhibit choline transport. Further more, we found that uptake under /ram-stimulation con ditions was saturable with a Km of 550 fiM. Our results were confirmed in a study by Grass), who used the same approach [4]. In addition he showed, by studying the inhibitory potency of a large number of organic cations, that at least two sites of interaction with the placental choline transporter can be postulated: a negative site that binds with the positively charged nitrogen and a site of hydrogen bonding that interacts with the primary alco hol. Furthermore, the degree of nitrogen group alkyla tion appeared to be of importance.
Since trophoblastic uptake is the rate-limiting step in fetal choline supply, interaction of maternally adminis-1873 tered drugs with the choline transporter at the microvil lus membrane could have clinical implications for fetal growth and development. This study was designed to investigate further the specificity of the choline trans porter at the syncytial microvillus membrane of the hu man placental trophoblast, by characterizing the inhibi tory potency and nature of the interaction of various cationic drugs. 
Preparation o f SMMV
SMMV were prepared from fresh human term placen tae according to an established method [5], which was further improved upon in our laboratory [3, 6]. Briefly, tissue was minced in a Waring blender and stirred for 30 min to loosen the microvilli. After MgCl2 aggregation and differential centrifugation, SMMV were harvested and suspended in the appropriate intravesicular buffer for uptake studies, to a final protein concentration of 10-15 mg/mL. Vesicles were frozen in liquid nitrogen and stored at -80° for four weeks at the maximum. This freezing and storage procedure did not influence choline uptake. 
RESULTS

Inhibitory potency of tetraalkylammonium compounds
In our previous study it was found that 5 mM TEA did not inhibit choline (250 jxM) uptake into SMMV [3], We Uptake of [3H]-choline into SMMV was measured in now investigated whether variation in the degree of alquadruplicate at 37° using a rapid filtration technique kyiation of TEA influences inhibitory potency. Enlarg ing the alkyl chains at the quaternary ammonium re-Whatman choline uptake ■ H I M filters (average pore size 0.7 fxm), and the radioactivity suited in a higher percentage of inhibition (Fig. 1) . The remaining on the filters counted in a Beckman LS 6000 LL liquid scintillation counter. Corrections were made for nonspecific filter binding. The exact conditions of the Table 1 . Apparent inhibitory constants of cationic drugs on transport experiments are given in the legends. Uptake is '1 " ,i ' expressed as pmol or nmol/mg protein or % of control uptake (mean ± SD), N representing the number of ex periments with different placentae.
Data analysis
From concentration vs % uptake curves of three con centrations of choline below Km (50, 125, and 250 uM increase in inhibitory potency of the compounds corre-¿ sponded well with the increase in lipophilicity as given by their calculated log P values [10]. Because of the surface tension lowering properties of tetraalkylammo-* nium compounds, we verified whether the vesicles stayed intact in the presence of the inhibitors. Only in the presence of THA was the equilibrium uptake of 250 |iM choline at 60 min significantly reduced as compared with control uptake. The other compounds did not inter fere with the membrane integrity.
Inhibition o f choline uptake by several organic cations
Plots of log concentration inhibitor vs % of control uptake of 250 (xM choline are shown in Fig. 2. The results of the nonlinear regression analysis of the typi cally sigmoid shaped curves are summarized in Table 1 . Marked differences in inhibitory potency can be seen between the organic cations tested. HC-3 inhibited choline uptake for 50% at a relatively low concentration, whereas the organic cation transport inhibitor mepiperphenidol and the anticholinergic drug atropine were less potent inhibitors. The H2-receptor antagonists cimetidine, ranitidine, and famotidine showed IC50 values only in the mM ranges. For TEA only a rough estimate of the IC50 value could be made, because of the very high concentrations (>10 mM) necessary to achieve half max imal inhibition. In all cases a two-site model did not fit the data better than a one-site model (P > 0.2).
Nature of interaction with the choline transporter
Although IC50 values provide a good measure of in hibitory potency, they cannot explain the nature of the interaction. We used the method of Dixon analysis to evaluate the type of choline transport inhibition by HC-3, atropine, and cimetidine. The concentration-depen dent inhibition of these compounds was measured at three choline concentrations: 50, 125, and 250 ^M. In creasing the substrate concentration decreased the inhib itory effectiveness of HC-3 and atropine, resulting in a lower IC50 value at a lower choline concentration. Trans formation of the data according to Dixon showed that the lines intersected above the X axis and to the left of the Y axis, indicating a competitive mode of interaction of HC-3 and atropine with the choline transporter (Fig. 3) . K¡ values for competitive inhibition, calculated from the Cheng-Prusoff equation for the three choline concentra tions, were 40 |xM for HC-3 and 1.2 mM for atropine (Table 1 ). In contrast, the IC50 value for cimetidine was independent of the choline concentration. Dixon analysis resulted in an intersection of the lines on the X axis, consistent with a noncompetitive type of interaction (Fig. 3) . Consequently, the K, for cimetidine equalled the ICjo value of 3.4 mM (Table 1) . 
DISCUSSION
